Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery
Phase 3 Completed
280 enrolled 12 charts
Dinaciclib and Epirubicin Hydrochloride in Treating Patients With Metastatic Triple-Negative Breast Cancer
Phase 1 Completed
40 enrolled
Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer
Phase 3 Completed
500 enrolled
Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage I or Stage II Breast Cancer
Phase 3 Completed
2,000 enrolled
Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast Cancer
Phase 3 Completed
2,250 enrolled
Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors
Phase 2 Completed
Combination Chemotherapy Following Surgery in Treating Women With Early Stage Breast Cancer
Phase 3 Completed
1,000 enrolled
Comparison of Three Combination Chemotherapy Regimens in Treating Women With Stage I or Stage II Breast Cancer
Phase 2 Completed
Combination Chemotherapy With or Without Capecitabine and/or Trastuzumab Before Surgery in Treating Women With Stage I, Stage II, or Stage III Breast Cancer
Phase 3 Completed
1,500 enrolled
Chemotherapy or Letrozole Before Surgery in Treating Postmenopausal Women With Breast Cancer That Can Be Removed By Surgery
Phase 3 Completed
756 enrolled
Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer
Phase 3 Completed
400 enrolled
Epirubicin and Thalidomide in Treating Patients With Liver Cancer
Phase 2 Completed
12 enrolled
Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery
Phase 3 Completed
280 enrolled
Combination Chemotherapy in Treating Women With Breast Cancer
Phase 3 Completed
446 enrolled
Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
Phase 3 Completed
Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor
Phase 1/2 Completed